Biotech firm Mirxes said to be considering secondary listing on SGX

Biotech firm Mirxes said to be considering secondary listing on SGX

A man checks his phone at the entrance of the Singapore Exchange Ltd. (SGX) headquarters in Singapore. Photographer: Ore Huiying/Bloomberg

Keertan Ayamany

04 August, 2023

Edited by: Pramod Mathew

HKEx MiRXES SGX

Printed by Unregistered user on Fri, 08 Aug 2025 13:28:11 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

SG biotech startup Mirxes files for Hong Kong IPO after $50m Series D funding

Biotech firm Mirxes said to be looking at raising up to $200m in Singapore IPO

Read more from Rest of Asia

SoftBank shares touch record high on Q1 earnings boost

FMO weighs $20m senior loan for Mongolia’s InvesCore